10 Most Promising Mid-Cap Healthcare Stocks According to Hedge Funds

Page 5 of 5

6. Mineralys Therapeutics Inc. (NASDAQ:MLYS)

Mineralys Therapeutics Inc. (NASDAQ:MLYS) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds.

On May 30, Mineralys Therapeutics Inc. (NASDAQ:MLYS) provided compelling data for the clinical efficacy of lorundrostat during the 35th European Meeting on Hypertension and Cardiovascular Protection. This clinical update comes after the company’s strategic focus on assisting patients with chronic kidney disease (CKD) in dealing with the combined burden of uncontrolled blood pressure.

The Phase 3 Launch-HTN trial analysis formally demonstrated significant, placebo-adjusted systolic blood pressure reductions of 9.6 mmHg in CKD participants and 12.2 mmHg in non-CKD populations over a standard 12-week period. For individuals with baseline albuminuria, the targeted therapeutic agent demonstrated a strong 52.2% decrease in the urine albumin-to-creatinine ratio in addition to a very good safety profile with few verified cases of hyperkalemia.

By aggressively increasing the clinical value of its diverse offers across high-risk patient groups, the company is hoping to obtain official regulatory permissions. Additionally, the U.S. Food and Drug Administration is presently reviewing Lorundrostat. The final PDUFA target action date is scheduled for December 22, 2026.

Mineralys Therapeutics Inc. (NASDAQ:MLYS) engages in the development of therapeutics that target illnesses caused by dysregulated aldosterone. It is working on the development of lorundrostat, an aldosterone synthase inhibitor for cardiorenal conditions. These include chronic kidney disease, hypertension, and obstructive sleep apnea.

While we acknowledge the potential of MLYS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MLYS and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Most Promising Mid-Cap Healthcare Stocks According to Hedge Funds.

Disclosure: None. Follow Insider Monkey on Google News.

Page 5 of 5
1281292 - 11759070 - 1